Coronavirus Disease 2019: Coronaviruses and Blood Safety

Transfusion Medicine Reviews

Volumn 34, Issue 2, 2020, Pages 75-80

  Chang, Le ^a,b   Yan, Ying ^a,b   Wang, Lunan ^a,b,c  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b BEIJING HOSPITAL   (China)

^c GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

2019 nCoV; Blood safety; Coronavirus; COVID 19; MERS; Pathogen inactivation technology; SARS; SARS CoV 2

Indexed keywords

VIRUS RNA;

BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; CORONAVIRINAE; CORONAVIRUS DISEASE 2019; HUMAN; ILLUMINATION; MICROBIAL DIVERSITY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; ULTRAVIOLET RADIATION; VIRUS GENOME; VIRUS INACTIVATION; VIRUS LOAD; VIRUS PNEUMONIA; VIRUS TRANSMISSION; ASYMPTOMATIC INFECTION; BETACORONAVIRUS; BLOOD; CHINA; CORONAVIRUS INFECTION; PANDEMIC; PUBLIC HEALTH; RISK; SEVERE ACUTE RESPIRATORY SYNDROME;

ASYMPTOMATIC INFECTIONS; BETACORONAVIRUS; BLOOD SAFETY; CHINA; CORONAVIRUS INFECTIONS; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PANDEMICS; PNEUMONIA, VIRAL; PUBLIC HEALTH; RISK; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 85082228140     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2020.02.003     Document Type: Review

References (57)

1. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet, 2020, 10.1016/s0140-6736(20)30183-5.
2. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003, https://www.who.int/csr/sars/country/table2004_04_21/en/; 2004 [accessed 2020-2-5].
3. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) https://www.who.int/emergencies/mers-cov/en/; 2013 [accessed 2020-2-5].
4. Shan, H., Zhang, P., Viral attacks on the blood supply: the impact of severe acute respiratory syndrome in Beijing. Transfusion 44 (2004), 467–469 http://doi.org/10.1111/j.0041-1132.2004.04401.x.
5. Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H.R., Becker, S., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348 (2003), 1967–1976 http://doi.org/10.1056/NEJMoa030747.
6. Grant, P.R., Garson, J.A., Tedder, R.S., Chan, P.K., Tam, J.S., Sung, J.J., Detection of SARS coronavirus in plasma by real-time RT-PCR. N Engl J Med 349 (2003), 2468–2469 http://doi.org/10.1056/nejm200312183492522.
7. Ng, E.K., Hui, D.S., Chan, K.C., Hung, E.C., Chiu, R.W., Lee, N., et al. Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin Chem 49 (2003), 1976–1980 http://doi.org/10.1373/clinchem.2003.024125.
8. Ng, E.K., Ng, P.C., Hon, K.L., Cheng, W.T., Hung, E.C., Chan, K.C., et al. Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. Clin Chem 49 (2003), 2085–2088 http://doi.org/10.1373/clinchem.2003.024588.
9. Corman, V.M., Albarrak, A.M., Omrani, A.S., Albarrak, M.M., Farah, M.E., Almasri, M., et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis 62 (2016), 477–483 http://doi.org/10.1093/cid/civ951.
10. World Health Organization. WHO recommendations on SARS and blood safety, https://www.who.int/csr/sars/guidelines/bloodsafety/en/; 2003 [accessed 2020-2-5].
11. Yin, Y., Wunderink, R.G., MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 23 (2018), 130–137 http://doi.org/10.1111/resp.13196.
12. Chen, Y., Liu, Q., Guo, D., Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol, 2020, 10.1002/jmv.25681.
13. Enjuanes, L., Zuniga, S., Castano-Rodriguez, C., Gutierrez-Alvarez, J., Canton, J., Sola, I., Molecular basis of coronavirus virulence and vaccine development. Adv Virus Res 96 (2016), 245–286 http://doi.org/10.1016/bs.aivir.2016.08.003.
14. Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H., et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 200 (2003), 282–289 http://doi.org/10.1002/path.1440.
15. de Wit, E., van Doremalen, N., Falzarano, D., Munster, V.J., SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14 (2016), 523–534 http://doi.org/10.1038/nrmicro.2016.81.
16. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020, 10.1056/NEJMoa2001017.
17. Cheng, P.K., Wong, D.A., Tong, L.K., Ip, S.M., Lo, A.C., Lau, C.S., et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 363 (2004), 1699–1700 http://doi.org/10.1016/S0140-6736(04)16255-7.
18. Hui, D.S.C., Zumla, A., Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am 33 (2019), 869–889 http://doi.org/10.1016/j.idc.2019.07.001.
19. US Food and Drug Administration. Revised recommendations for the assessment of donor suitability and blood product safety in cases of suspected severe acute respiratory syndrome (SARS) or exposure to SARS: guidance for industry, https://www.fda.gov/media/124354/download; 2003.
20. Wang, H., Mao, Y., Ju, L., Zhang, J., Liu, Z., Zhou, X., et al. Detection and monitoring of SARS coronavirus in the plasma and peripheral blood lymphocytes of patients with severe acute respiratory syndrome. Clin Chem 50 (2004), 1237–1240 http://doi.org/10.1373/clinchem.2004.031237.
21. Li, L., Wo, J., Shao, J., Zhu, H., Wu, N., Li, M., et al. SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. J Clin Virol 28 (2003), 239–244 http://doi.org/10.1016/s1386-6532(03)00195-1.
22. Yilla, M., Harcourt, B.H., Hickman, C.J., McGrew, M., Tamin, A., Goldsmith, C.S., et al. SARS-coronavirus replication in human peripheral monocytes/macrophages. Virus Res 107 (2005), 93–101 http://doi.org/10.1016/j.virusres.2004.09.004.
23. Law, H.K., Cheung, C.Y., Ng, H.Y., Sia, S.F., Chan, Y.O., Luk, W., et al. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106 (2005), 2366–2374 http://doi.org/10.1182/blood-2004-10-4166.
24. Hung, I.F., Cheng, V.C., Wu, A.K., Tang, B.S., Chan, K.H., Chu, C.M., et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 10 (2004), 1550–1557 http://doi.org/10.3201/eid1009.040058.
25. Poon, T.C., Chan, K.C., Ng, P.C., Chiu, R.W., Ang, I.L., Tong, Y.K., et al. Serial analysis of plasma proteomic signatures in pediatric patients with severe acute respiratory syndrome and correlation with viral load. Clin Chem 50 (2004), 1452–1455 http://doi.org/10.1373/clinchem.2004.035352.
26. Schmidt, M., Brixner, V., Ruster, B., Hourfar, M.K., Drosten, C., Preiser, W., et al. NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion 44 (2004), 470–475 http://doi.org/10.1111/j.1537-2995.2004.03269.x.
27. Woo, P.C., Lau, S.K., Tsoi, H.W., Chan, K.H., Wong, B.H., Che, X.Y., et al. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 363 (2004), 841–845 http://doi.org/10.1016/s0140-6736(04)15729-2.
28. Zhou, Y.H., Prevalence of non-pneumonic infections with SARS-correlated virus. Lancet 363 (2004), 1825–1826 author reply 6-7. http://doi.org/10.1016/s0140-6736(04)16313-7.
29. Young M. Prevalence of non-pneumonic infections with SARS-correlated virus. Lancet 2004;363: 1826; author reply -7. http://doi.org/10.1016/s0140-6736(04)16314-9.
30. Yip, C.W., Hon, C.C., Zeng, F., Chow, K.Y., Leung, F.C., Prevalence of non-pneumonic infections with SARS-correlated virus. Lancet, 363, 2004, 1825 author reply 6-7. http://doi.org/10.1016/s0140-6736(04)16311-3.
31. Theron, M., Prevalence of non-pneumonic infections with SARS-correlated virus. Lancet, 363, 2004, 1825 author reply 6-7. http://doi.org/10.1016/s0140-6736(04)16312-5.
32. Shang, G., Biggerstaff, B.J., Yang, B., Shao, C., Farrugia, A., Theoretically estimated risk of severe acute respiratory syndrome transmission through blood transfusion during an epidemic in Shenzhen, Guangdong, China in 2003. Transfus Apher Sci 37 (2007), 233–240 http://doi.org/10.1016/j.transci.2007.09.004.
33. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D., Fouchier, R.A., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367 (2012), 1814–1820 http://doi.org/10.1056/NEJMoa1211721.
34. Chafekar, A., Fielding, B.C., MERS-CoV: understanding the latest human coronavirus threat. Viruses, 10, 2018 http://doi.org/10.3390/v10020093.
35. American Association of Blood Banks. Middle East respiratory syndrome coronavirus, http://www.aabb.org/tm/eid/Documents/middle-east-respiratory-syndrome-coronavirus.pdf; 2013 [accessed 2020-2-5].
36. Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020, 10.1056/NEJMoa2001316.
37. Chan, J.F., Yuan, S., Kok, K.H., To KK, Chu, H., Yang, J., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, 10.1016/S0140-6736(20)30154-9.
38. Phan, L.T., Nguyen, T.V., Luong, Q.C., Nguyen, T.V., Nguyen, H.T., Le, H.Q., et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med, 2020, 10.1056/NEJMc2001272.
39. Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med, 2020, 10.1056/NEJMc2001468.
40. Holshue, M.L., DeBolt, C., Lindquist, S., Lofy, K.H., Wiesman, J., Bruce, H., et al. First case of 2019 novel coronavirus in the United States. N Engl J Med, 2020, 10.1056/NEJMoa2001191.
41. Control Ecfdpa. Outbreak of acute respiratory syndrome associated with a novel coronavirus, Wuhan, China; first update, https://www.ecdc.europa.eu/sites/default/files/documents/Risk-assessment-pneumonia-Wuhan-China-22-Jan-2020.pdf; 2020 [accessed 2020-2-5].
42. American Association of Blood Banks. Update: impact of 2019 novel coronavirus and blood safety, http://www.aabb.org/advocacy/regulatorygovernment/Documents/Impact-of-2019-Novel-Coronavirus-on-Blood-Donation.pdf; 2020 [accessed 2020-2-5].
43. Rabenau, H.F., Cinatl, J., Morgenstern, B., Bauer, G., Preiser, W., Doerr, H.W., Stability and inactivation of SARS coronavirus. Med Microbiol Immunol 194 (2005), 1–6 http://doi.org/10.1007/s00430-004-0219-0.
44. Lamarre, A., Talbot, P.J., Effect of pH and temperature on the infectivity of human coronavirus 229E. Can J Microbiol 35 (1989), 972–974 http://doi.org/10.1139/m89-160.
45. Eickmann, M., Gravemann, U., Handke, W., Tolksdorf, F., Reichenberg, S., Muller, T.H., et al. Inactivation of three emerging viruses—severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus—in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light. Vox Sang, 2020, 10.1111/vox.12888.
46. Hashem, A.M., Hassan, A.M., Tolah, A.M., Alsaadi, M.A., Abunada, Q., Damanhouri, G.A., et al. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates. Transfus Med 29 (2019), 434–441 http://doi.org/10.1111/tme.12638.
47. Hindawi, S.I., Hashem, A.M., Damanhouri, G.A., El-Kafrawy, S.A., Tolah, A.M., Hassan, A.M., et al. Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light. Transfusion 58 (2018), 52–59 http://doi.org/10.1111/trf.14422.
48. Eickmann, M., Gravemann, U., Handke, W., Tolksdorf, F., Reichenberg, S., Muller, T.H., et al. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively. Transfusion 58 (2018), 2202–2207 http://doi.org/10.1111/trf.14652.
49. Darnell, M.E., Taylor, D.R., Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products. Transfusion 46 (2006), 1770–1777 http://doi.org/10.1111/j.1537-2995.2006.00976.x.
50. Rabenau HF, Biesert L, Schmidt T, Bauer G, Cinatl J, Doerr HW. SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation. Biologicals 2005;33: 95-9. http://doi.org/10.1016/j.biologicals.2005.01.003.
51. Lin, L., Hanson, C.V., Alter, H.J., Jauvin, V., Bernard, K.A., Murthy, K.K., et al. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 45 (2005), 580–590 http://doi.org/10.1111/j.0041-1132.2005.04316.x.
52. Yunoki, M., Urayama, T., Yamamoto, I., Abe, S., Ikuta, K., Heat sensitivity of a SARS-associated coronavirus introduced into plasma products. Vox Sang 87 (2004), 302–303 http://doi.org/10.1111/j.1423-0410.2004.00577.x.
53. Leclercq, I., Batejat, C., Burguiere, A.M., Manuguerra, J.C., Heat inactivation of the Middle East respiratory syndrome coronavirus. Influenza Other Respir Viruses 8 (2014), 585–586 http://doi.org/10.1111/irv.12261.
54. Keil, S.D., Bowen, R., Marschner, S., Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment. Transfusion 56 (2016), 2948–2952 http://doi.org/10.1111/trf.13860.
55. Rebulla, P., The long and winding road to pathogen reduction of platelets, red blood cells and whole blood. Br J Haematol 186 (2019), 655–667 http://doi.org/10.1111/bjh.16093.
56. Seltsam, A., Muller, T.H., Update on the use of pathogen-reduced human plasma and platelet concentrates. Br J Haematol 162 (2013), 442–454 http://doi.org/10.1111/bjh.12403.
57. Chinese Society of Blood Transfusion. Recommendations on blood collection and supply during the epidemic of novel coronavirus pneumonia in China (1st edition) [Chinese], https://www.csbt.org.cn/plus/view.php?aid=16530; 2020 [accessed 2020-2-5].